Mayne Pharma Group (OTCMKTS:MAYNF) Shares Down 3% – Here’s Why

Mayne Pharma Group Limited (OTCMKTS:MAYNF)’s share price dropped 3% on Tuesday . The stock traded as low as $2.0750 and last traded at $2.0750. Approximately 18,057 shares traded hands during trading, an increase of 120% from the average daily volume of 8,214 shares. The stock had previously closed at $2.14.

Mayne Pharma Group Price Performance

The company’s 50 day simple moving average is $2.41 and its 200 day simple moving average is $3.04.

Mayne Pharma Group Company Profile

Mayne Pharma Group (OTCMKTS:MAYNF) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of prescription products. The company’s portfolio spans oral, transdermal and topical dosage forms, with a particular emphasis on women’s health, dermatology, pain management and other niche therapeutic areas. Through both branded and generic offerings, Mayne Pharma seeks to address unmet patient needs and provide cost-effective alternatives to established treatments.

In its development operations, Mayne Pharma leverages a combination of in-house research and external partnerships to advance product candidates through regulatory review.